Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Peltopepimut-s by ISA Pharmaceuticals for Oropharyngeal Cancer: Likelihood of Approval
Peltopepimut-s is under clinical development by ISA Pharmaceuticals and currently in Phase II for Oropharyngeal Cancer. According to GlobalData, Phase...
Peltopepimut-s by ISA Pharmaceuticals for Human Papillomavirus (HPV) Associated Cancer: Likelihood of Approval
Peltopepimut-s is under clinical development by ISA Pharmaceuticals and currently in Phase II for Human Papillomavirus (HPV) Associated Cancer. According...
Peltopepimut-s by ISA Pharmaceuticals for Cervical Cancer: Likelihood of Approval
Peltopepimut-s is under clinical development by ISA Pharmaceuticals and currently in Phase II for Cervical Cancer. According to GlobalData, Phase...